Urethral Stricture. Urethral stricture
Conditions
Interventions
Intervention 1: Intervention group: one sustained-release Diclofenac tablet (100mg) Sobhan Darou taken orally 10 hours before urethral dilatation. Intervention 2: Control group: one tablet of Placebo
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
20 Years to No maximum
Inclusion criteria
Inclusion criteria: Male gender Older than 20 years old Single urethral stricture and stricture length less than 1.5 cm
Exclusion criteria
Exclusion criteria: Urethral stricture due to Balanitis Xerotica Obliterans History of hepatic, renal or gastric diseases Patient refusal of participation History of NSAID Hypersensitivity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain during urethral dilatation. Timepoint: Immediately after urethral dilatation. Method of measurement: Based on Visual Analogue Scale.;Pain 1 hour after urethral dilatation. Timepoint: 1 hour after urethral dilatation. Method of measurement: Based on Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| The need to take analgesics. Timepoint: 24 hours after urethral dilatation. Method of measurement: Yes or No.;Side effects due to Diclofenac. Timepoint: 24 hours after urethral dilatation. Method of measurement: Yes or No. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Abbas Asadpour
Mashhad University of Medical Sciences
Outcome results
None listed